INBICON A/S: Financial statements 2025
CVR: 27036635
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
INBICON A/S (CVR 27036635) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000. The solvency ratio was 99.9%.
- Revenue
- DKK 0
- Profit/Loss
- DKK -3,447,000
- Equity
- DKK 35,752,000
- Total Assets
- DKK 35,775,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | - | -3.4 mio. | 35.8 mio. | - |
| 2024 | 1.4 mio. | - | 7.2 mio. | 39.2 mio. | - |
| 2023 | - | - | 280 t. | 32 mio. | - |
| 2022 | 0 | -498 t. | -319 t. | 31.7 mio. | - |
| 2021 | 0 | -518 t. | -1.6 mio. | 32 mio. | - |
Official annual report
How creditworthy is INBICON A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
INBICON A/S has published its annual report for 2024. Revenue came to DKK 1,368,000, and the net result was DKK 7,237,000.
As of February 27, 2025, Ole Thomsen has joined the board of directors of INBICON A/S.
As of February 27, 2025, Jens Grymer has joined the board of directors of INBICON A/S.
As of February 27, 2025, Mikael Brandt has left the board of directors of INBICON A/S.
As of February 26, 2025, Ole Thomsen has left the board of directors of INBICON A/S.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.